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Teaser This review highlights routinely omitted facts on human coronary morphology and
on paradoxical patterns of lipid deposition in initiation of coronary atherosclerosis. The
analysis offers an alternative hypothesis on the pathogenesis of coronary atherosclerosis.
Excessive intimal hyperplasia in human
coronary arteries before intimal lipid
depositions is the initiation of coronary
atherosclerosis and constitutes a therapeutic
target
Vladimir M. Subbotin
602 Samuel Drive, Madison, WI 53717, USA
The consensus hypothesis on coronary atherosclerosis suggests high LDL-C
levels as the major cause and pursues it as the therapeutic target, explicitly
assuming: (i) tunica intima of human coronaries consists of only one cell
layer – endothelium, situated on a thin layer of scarcely cellular matrix; and
(ii) subendothelial lipoprotein retention initiates the disease. Facts showed:
(i) normal tunica intima invariably consists of multiple cellular layers; and
(ii) initial lipid depositions occurred in the deepest layers of tunica intima.
This review suggests that coronary atherosclerosis starts with pathological
intimal expansion, resulting in intimal hypoxia and neovascularization
from adventitial vasa vasorum, facilitating lipoprotein extraction by
previously avascular deep intimal tissues. Until the hypothesis incorporates
real knowledge, our efforts will probably be off-target.
Introduction
The enormously costly drug discovery process today cannot predict the clinical efficacy or
sustainability of prospective drugs because of our failure (or limited ability) to identify the
biologic mechanisms of diseases (i.e., disease pathogenesis) [1–5]. I suggest that the same sort of
failure has thwarted progress in the therapeutic treatment of coronary artery pathology. Another
matter that hinders the progress in studying coronary artery pathology is that the main
pathologic alterations occur only after the coronary artery wall undergoes certain age-related
differentiation. For example, coronary atherosclerosis can affect the coronary wall only after its
tunica intima differentiates from a thin, one-cell-layer compartment into a thick, multi-cell-
layered compartment, in a process called normal [6] or benign [7–9] diffuse intimal thickening
(DIT). This makes it tempting to designate DIT as the beginning of coronary atherosclerosis [10–
13]. However, coronary DIT occurs in all human hearts without any exception, as well as in all
animals with mass comparable to human body mass, which by default makes coronary DIT a
normal physiologic arrangement. This misinterpretation (a phenotype occurring in all repre-
sentatives without exception is perceived as a pathology, although must be perceived as the
norm) could potentially jeopardize drug discovery in two ways: (i) a norm that is misguidedly
suggested as pathology could be a false therapeutic target; and (ii) designation of a pathogenic
status to an erroneous event could divert our efforts in search for real causation(s).
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their suggested causes: (i) coronary atherosclerosis (high low-density
lipoprotein cholesterol (LDL-C) levels, endothelial dysfunction and
inflammation); (ii) re-stenosis following interventions and coronary
bifurcation disease (mechanical injury and/or stress); (iii) transplant
coronary disease (immunologic damage); (iv) Kawasaki disease (in-
fectious etiology and genetic factors); (v) coronary pathology in
Hutchinson–Gilford progeria (synthesis of progerin). The study of
each disease is aimed at the particular presumed causation as the
therapeutic target. However, growing evidence has showed that
increased cell proliferation in the coronary tunica intima, transform-
ing normal DIT into excessive intimal hyperplasia or pre-pathologic
intimal thickening (pre-PIT), is the initiation of all of the above
diseases. Excessive intimal hyperplasia can be itself lethal by nar-
rowing the coronary lumen or becoming complicated by plaque
formation. Accumulating evidence shows that excessive cell prolif-
eration in the coronary tunica intima can be triggered by a variety of
diverse, nonspecific signals. However, studying nonspecific signals
in the hope of elucidating normal regulation, and finding a thera-
peutic target, is unproductive. This review suggests that, unless we
change our approach to coronary pathology and concentrate on
disease initiation (i.e., on excessive intimal hyperplasia in the
coronary tunica intima), our research and therapeutic efforts will
probably be off-target. This inquiry opens with an analysis of coro-
nary atherosclerosis because it is the most frequent and lethal
coronary malady. Because the main goal of this review is to present
arguments in favor of coronary cell proliferation as the initiation of
all of the above coronary diseases, the arguments on the initiation of
coronary atherosclerosis are given in greater detail than those for
other coronary pathologies; arguments on other coronary patholo-
gies are grounded on the same reasoning.
Coronary atherosclerosis
Brief history of coronary morphology
Understanding the pathogenesis of any of disease always starts with
a construction of undisputed knowledge on an organ’s normal
morphology and its variations under physiologic conditions. In
the field of arterial pathology, the modern understanding of arterial
design starts with the pioneering work of Richard Thoma. Over four
decades, Thoma published observations and hypotheses in leading
pathology journals about the resemblance between normal diffuse
intimal hyperplasia (now termed DIT) and arteriosclerotic intimal
thickening (now termed PIT) in different segments of the aorta, the
coronary artery and other arteries. He has also published articles on
similarities between the above structures and morphogenesis lead-
ing to the closure of the umbilical artery and the ductus arteriosus. In
his publications, Thoma uses the German ‘Neubildung’ or ‘Gewebs-
neubildung’ to describe new tissue formation without pathologic
transformation [i.e., normal hyperplasia (DIT)]. To describe a dis-
eased hyperplasia (PIT), he adds the terms ‘Angiosklerose’ and
‘Angiomalacie’. Thoma hypothesized that arterial intimal thicken-
ing is a physiological adaptation to changing hemodynamic
demands [14–17]. In one publication (coauthored by his student
N. Kaefer), Thoma suggested that the pathogenesis of arterioscle-
rosis begins with intimal thickening that is initially adaptive [18]
(for a review see [19]). Whether one agrees or not with Thoma’s ‘first
histomechanical laws of the bloodstream’ [16], it is undisputed that
he laid the foundation for coronary pathology.Pioneering work of Kapitoline Wolkoff
The same year (1923) the final manuscript of Richard Thoma
appeared in Virchows Archiv [17], the journal published another
groundbreaking report concerning normal postnatal development
of the human coronary artery, contributed by Dr Kapitoline Wolk-
off (alternatively spelled Kapitolina Volkova) from St Petersburg,
Russia. I believe that the significance of this report deserves special
attention. For the first time, Wolkoff showed that normal human
epicardial coronary arteries undergo postnatal developmental
changes, gradually transforming their morphology from the after
birth design to an adult architecture at an age of 15–30 years. (A
personal note: I often cite works that are old. I become so preoccu-
pied with an idea that I must find out who first discovered the facts.
However, regardless of personal compulsion, I believe that if some-
one has overlooked crucial information published a hundred years
ago they should update their knowledge). In particular, Wolkoff
showed that the coronary tunica intima of young children (e.g.,
8.5 months) consists of only 1–2 layers of cells lying on a thin
amount of matrix and internal elastic lamina. With age, the num-
ber of cell layers in the tunica intima increases, reaching 10–15 layers
at age 15. This structure then differentiates to the adult design of
approximately 25–30 cell layers at age 25–30 years (Fig. 1).
From Wolkoff’s descriptions, the structures of tunica intima
above a lamina elastica interna (in German ‘Bindegewebsschicht’
and ‘Elastisch-hyperplastische Schicht’) correspond to DIT in the
modern literature [6,21]. Wolkoff’s publication came from the
Department of Pathologic Anatomy of the Institute of Experimen-
tal Medicine St Petersburg, Russia, headed by N.N. Anitschkow
(alternatively spelled Anichkov), who is famous for his seminal
work in experimental atherosclerosis. Dr Wolkoff was a disciple of
Anitschkow and a lifelong colleague. A crucial significance of
Wolkoff’s findings has been acknowledged by Anitschkow in
the opening chapter of the prominent book: Arteriosclerosis: A
Survey of the Problem. In his chapter, Anitschkow writes: ‘‘. . . in
evaluating the significance of the thickening of the intima, as
observed by various authors, it is important to remember that
thickening of the intima also occurs in experimental animals as a
purely physiological phenomenon in the process of aging. In this
respect, the arteries of some animals exhibit almost the same
conditions that are observed in human arteries, as may be seen
from Miss Wolkoff’s investigation (1924). In the view of the fact
that some authors mentioned above did not pay any attention to
this circumstance, the experimental results reported by them can
be accepted only with very great reservations. This criticism
applies only to experimental animals of considerable size, like
dogs, which invariably exhibit thickening of the intima as a sign of
aging. . .’’ [22]. Anitschkow referred to Wolkoff’s 1923 publication
[20] and the second article Wolkoff published in Virchows Archiv in
1924 that compared her previous observations of the human
coronary artery [20] with those of the arterial morphology of
animals [23]. The quotation above showed that the greatest au-
thority in the field suggested that researchers, who were not aware
of normal coronary artery intimal thickening in humans and
animals, simply cannot be trusted in their results and conclusions.
One might expect that such a straightforward warning by the most
respectable scientist in the field would not be missed or forgotten.
The following years brought numerous publications on coro-
nary artery design in humans and large mammals. All of themwww.drugdiscoverytoday.com 1579
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FIGURE 1
Selected drawing of human coronary arteries adapted, with permission, from [20]. (a) 8.5 months, (b) 15 years, (c) 32 years (all females). Red bars indicate the
thickness of the tunica intima. The original article does not show microscopic magnifications; however they could be inferred as: (a) and (b) 400; (c) 200.
Source: Reproduced, with permission, from [20].
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nary arteries of humans and large mammals invariably develops
under physiologic conditions into normal intimal hyperplasia or
DIT [24–47]. This arterial morphogenesis was particularly well
described in great detail by French [25–27], Ba´lint [42], Velicans
[28–40] and Cucu [46,47]. Therefore, has knowledge on coronary
morphology prevailed and the misinterpretation been resolved?
Known facts on human coronary morphology continue to be
ignored in spite of accumulated evidence
Reality is surprising: known facts on coronary artery morphology
continue to be ignored in coronary research. Furthermore, in
1989, the renowned UK pathologist Collin L. Berry in the mono-
graph Diseases of the Arterial Wall alerted the research community
again: ‘‘There is a considerable body of literature on the signifi-
cance of what have usually been described as ‘endothelial cush-
ions’, mainly in coronary arteries (see Robertson for review of early
literature). Robertson concluded that the lesions, which could be
found in other arteries, were not related to subsequent atheroscle-
rosis but were normal growth phenomenon. These studies how-
ever, and the subsequent careful work of the Velicans, have been
ignored in recent years’’. [48].
Unfortunately, Berry’s assessment in the year 1989 remains
valid. Facts of normal human coronary morphology (i.e., obligatory
development of DIT in human epicardial arteries) continue to be
ignored (or overlooked) in scientific publications, for example [49–
53], and educational material, for example [54–56]. All mainstream
research and educational writings continue to be based on the
incorrect assumption that the human coronary tunica intima com-
prises only one cell layer. These omissions could be caused by
inertia in medical education and infrequent usage of specialized
medical histology textbooks that contain correct information,1580 www.drugdiscoverytoday.comincluding, for example, Histology for Pathologists [57]. I would
conditionally have agreed with such an interpretation, but not
after the year 2002. In 2002, Virchows Archiv published a detailed
article by Nakashima et al. [21], bringing an end to any misinter-
pretation and doubt on normal human coronary design. This
publication contains detailed information on the postnatal devel-
opmental morphology of the human coronary artery, particularly
of the tunica intima (Figs. 2 and 3). Nakashima et al. performed the
detailed analysis that undoubtedly documented that: (i) the normal
adult coronary tunica intima is thicker than the tunica media; and (ii)
the tunica intima comprises numerous cell layers of smooth alpha-
actin-positive cells, which are arranged in a very dense manner,
two-thirds of the intimal thickness, with the cell layer density
progressively increasing toward the internal elastic lamina.
This morphologic study was published in Virchows Archiv – a
most prestigious international journal in pathology – and received
notable citation scores: currently 47 (Web of Science) and 81
(Google Scholar). Therefore, one should anticipate that, after this
publication in 2002, all studies on coronary atherosclerosis would
be grounded on well-documented facts of coronary artery mor-
phology, and all reservations and objections expressed by Anitsch-
kow and Berry should no longer be of concern; but, as my readers
have probably already guessed, this is not the case.
To date arteriosclerosis research has taken no cognizance of
fundamental facts about human coronary artery morphology
Today, mainstream analyses of the pathogenesis of coronary ath-
erosclerosis continue to be based on the incorrect information
about coronary artery design. No matter how unrealistic it sounds,
the facts are stubborn and astonishing. All chief publications
presenting theories on the pathogenesis of coronary atherosclero-
sis and possible solutions are based on the explicit assumption that
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FIGURE 2
DIT in proximal coronary arteries. (a) Right coronary artery (RCA), 7-day-old female. (b) Left anterior descending artery (LAD), 5-year-old female. (c) LAD, 15-year-
old female. (d) LAD, 29-year-old female. Bars in a, b, c and d represent 25 mm, 50 mm, 50 mm and 100 mm, respectively. I represents the intima and M is the media.
These microscopic images represent normal morphological changes in coronary arteries from birth to adult (van Gieson stain). Please note that the tunica intima
of a normal coronary artery is thicker than the tunica media.
Source: Reproduced, with permission, from [21].
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layer of cells, endothelial cells, situated on a thin layer of acellular
(or scarcely cellular) matrix. This incorrect information appeared
as written descriptions and as detailed schematics in analyses of
the disease pathogenesis and approaches to a cure. To illustrate the
above misrepresentation, I have chosen a dozen recent publica-
tions that have presented incorrect information as written descrip-
tions and drawings and I encourage my readers to review these
articles [58–70]. My conclusions on the erroneous status in this
field can be demonstrated by the following figure from one the
most recent publications from 2015 [69] (Fig. 4).
At this point I should like invite my readers to review again figures
from Nakashima et al. [21], which are real microscopic images of
human coronary arteries, and compare them to the depiction of the
coronary tunica intima given here in Fig. 4. My readers do not have to
be pathologists to discover a fundamental difference: numerous
(25–30) compactly arranged cell layers of the real coronary tunica
intima puzzlingly disappeared in Fig. 4 [69]. This incorrect represen-
tation of coronary morphology has been further repeated by popu-
lar medical websites (e.g., Medscape [71]) and is further amplified by
science writings (e.g., [72]) and even by the most reputable infor-
mational source – Encyclopedia Britannica (Fig. 5).
The most recent book on coronary artery disease by J.T. Willerson
[74] incorporates the same incorrect representation of coronarymorphology [75]. By contrast, all real microscopic studies of human
coronary arteries undoubtedly confirmed that tunica intima of
epicardial arteries is thicker than tunica media and consists of
multiple layers of cells [76]. Someone might ask the following
question: is an adherence to the correct coronary architecture really
that important for coronary atherosclerosis research? Why do I
devote so much attention to incorrect writings and schematics that
omit real details of coronary tunica intima morphology? A general
response is that science cannot omit or distort facts. Although it
sounds trivial and redundant, this process is important.
Why human coronary tunica intima design must be recognized
as a multi-layered cellular compartment
The specific answer as to why human coronary tunica intima design
must be recognized as a multilayered cellular compartment has
been highlighted by another groundbreaking report from Naka-
shima’s group [77]. In this detailed study, Nakashima and coau-
thors showed that the initiation of coronary atherosclerosis started
with lipid depositions in deep layers of the tunica intima, which are
distal to the coronary lumen and separated from the luminal blood
by numerous intimal cell layers and matrix. At the same time, the
subendothelial space and the region proximal to the arterial lumen
of the tunica intima do not show any lipid accumulation. The
initial lipid deposition occurred immediately above the internalwww.drugdiscoverytoday.com 1581
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FIGURE 3
Structures and components of diffuse intimal thickening (DIT) in the proximal portion of the right coronary artery (RCA) in adults. (a,b) DIT was demonstrated as a
uniformly thickened inner layer (van Gieson). (c) Immunostain for alpha smooth muscle actin. Almost all the cells in the DIT were smooth muscle cells. (d)
Immunostain for the macrophage marker HAM56 at the same site as in (c). Only a few intimal and several adventitial cells were positive (arrowheads). I represents
the intima, M is the media and A is the adventitia. These microscopic images represent a normal right adult coronary artery in two intersecting planes. Please note
that the tunica intima of a normal coronary artery is thicker than the tunica media.
Source: Reproduced, with permission, from [21].
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Even with the progression of lipid deposition, lipid accumulation
is always greater in deeper tunica intima than in surface layers
[77,78]. Notably, these deep lipid deposits do not coincide with
macrophage infiltration even at Grade 3 PIT with foam cells
(Fig. 6).
The facts that Nakashima et al. reported [77,78] have placed the
sequence of events in a straightforward order: at the Grade 1 fatty
streak (Fig. 6d–f) lipids visibly accumulated in the deepest layers of
the tunica intima, which are distal to the arterial lumen, whereas
the subendothelial region and the outer tunica intima proximal to
the lumen do not show any trace of lipid accumulation. At the
Grade 2 fatty streak (Fig. 6g–i) lipid accumulation in the inner
(distal to lumen) layers of the tunica intima increased, whereas the
outer layers proximal to the blood region are either lipid-free or
show much less lipid accumulation. At Grade 3 PIT, accumulation
of lipids in the outer tunica intima, which is distal to the arterial
lumen, dominated compared with tissues proximal to the arterial
lumen (Fig. 6m–o). The same paradoxical pattern of initial deep
lipid deposition in human coronary atherosclerosis was also noted
in early publications by Wolkoff in 1929 [79] and others [80,81].
I wish to emphasize again that the above observations represent
initiation of coronary atherosclerosis.1582 www.drugdiscoverytoday.comWe must direct our attention to the initiation of coronary
atherosclerosis when pathologic alterations are potentially
reversible
Reviewing the current literature on the pathogenesis of coronary
atherosclerosis has shown that chief analyses essentially do not
discuss the disease pathogenesis. The word ‘pathogenesis’ comes
from the Greek pathos (disease) and genesis (creation) and is inter-
preted as ‘the origination and development of a disease’ [82] or in
plain language ‘events from which a disease begins and then
progresses’. Logically, all studies that are devoted to atherosclerotic
plaque properties (i.e., plaque stability, vulnerability, rupture and
thrombosis) are not about initiation or pathogenesis of coronary
atherosclerosis but about inevitable complications of end-stages of
the disease [83–85]. Understandably, from a lifesaving perspective,
we must study atherosclerotic plaque status and plaque vulnerabil-
ity, rupture and thrombosis, because these features determine
morbidity and mortality. Needless to say, many studies of disease
pathogenesis aim for prevention and reversal of pathology but,
unfortunately, these end-stage manifestations of coronary athero-
sclerosis are beyond prevention and reversal and are extremely
resistant to therapeutic stabilization [83–85]. Although some prog-
ress in plaque stabilization and regression has been reported, these
pathologic formations are unlikely to be therapeutically curable,
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FIGURE 4
Classic incorrect presentation of coronary artery morphology. Please note that the tunica intima is shown as one layer of endothelial cells covering the acellular
matrix. According to this schematic and the corresponding text, all other noninflammatory cells appeared in the tunica intima only after atherosclerotic lesion
occurred.
Source: Reproduced, with permission, from [69].
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intervention (for a review see [86]). Again, studies of advanced
stages are extremely important because their results help to save
lives but it is unlikely that they could bring an understanding of the
disease genesis (i.e., to answer questions regarding how and why
the disease occurs and how to prevent it). Therefore, we must not
pretend that studying atherosclerotic plaque properties is the study
of how the disease begins, because, on the contrary, it is how the
disease ends. This review aims to analyze mechanisms of the
initiation of coronary atherosclerosis (i.e., Grade 1–2 fatty streak
and Grade 3 PIT) when lipid accumulation occurs within still viable
coronary structures. Attention to the early stages is crucial because
pathological alterations at these stages are potentially interruptible
and reversible.
The accepted vector of lipid invasion (from coronary luminal
blood into the coronary wall) is incoherent
The accepted hypothesis on the initiation of coronary atheroscle-
rosis assumes that lipids invade the coronary wall from the arterial
lumen. However, when the hypothesis is combined with undeni-
able facts on patterns of initial lipid deposition [77–81], it inevitably
implies a self-contradictory model in which lipids from the arterial
lumen have invaded and accumulated in the distal deeper layers of
DIT, thereby passing through the proximal subendothelial regionand the surface layers of DIT, but nevertheless leaving no trace in
the proximal tissues. To rationalize this paradoxical distribution
pattern, the accepted hypothesis has to be complemented by
certain conditions because a parsimonious explanation for such
paradoxical patterning does not exist.
From this point forward, I prefer to use to use the term ‘consen-
sus hypothesis’ instead of ‘accepted hypothesis’ for the following
reasons. First, it is not known how many scientists accept or reject
the hypothesis. Second, the events surrounding the initiation of
coronary atherosclerosis were the subjects of very heated and
unsettled debates over the disease pathogenesis, a summary of
which was termed the ‘consensus statement’ in 1985 [87–91]. The
third reason is that I was convinced by a recent publication of
Malone and Agutter [92] that the term consensus hypothesis is
more appropriate wording that better defines the circumstances.
In their writing, Malone and Agutter argue in favor of their
hypothesis of the pathogenesis of deep vein thrombosis and
appropriately use the word consensus to describe a mainstream
hypothesis in their field of research that they opposed.
To reconcile the consensus hypothesis (with lipid invasion
from the arterial lumen) with the discovered facts (no initial
lipid deposition in tissues proximal to the lumen but visible
deposition in tissues distal to the lumen), Nakashima et al.
invoked an elegant hypothesis [77,78] that incorporateswww.drugdiscoverytoday.com 1583
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FIGURE 5
Depiction of normal human coronary artery (left) and coronary atherosclerosis (right). Please note that the tunica intima is presented here as one layer of
endothelial cells covering the acellular matrix, which is incorrect.
Source: By courtesy of Encyclopedia Britannica; reproduced, with permission, from [73].
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to their discovery on the co-localization of proteoglycan bigly-
can (which has a high binding capacity for lipoproteins [95–97])
in distal layers of coronary tunica intima [77,78]. However,
localization of proteoglycan biglycan in the outer (distal) layers
of DIT [77,78] can offer only a partial explanation: biglycan also
localized in different tissues of the human body [98] including
cancer tissues [99], but tissues other than the outer coronary
tunica intima do not show pathologic lipid accumulation in
regard to biglycan.
Scientists working on mathematical modeling of atherosclerosis
[100,101] also favored a filtration pressure model [93] with a
constant radially outward flow of plasma into the tunica intima
caused by arterial blood pressure. In particular, Dr. Fok suggested a
model with physical transport of LDL-C from the proximal parts of
the intima to the distal parts, followed by washing out from the
distal parts by blood; then the LDL-C accumulates near the elastic
lamina because of the presence of biglycan and the permeability
block by lamina elastica interna [102]. Although the models are well-
designed, they are incongruent with known patterns of lipid accu-
mulation resulting from the same diffusion pressure and LDL-C
invasion in the tunica intima of nondiseased human aortas [103].
History of the presumption on lipid invasion from arterial
luminal blood into coronary wall and alternative hypotheses
Therefore, the question is: why does atherosclerosis research ad-
vocate this self-contradictory model of LDL-C deposition from the1584 www.drugdiscoverytoday.comcoronary artery lumen to the coronary tunica intima if it is in
conflict with known observations? There ought to be a reason why
coronary atherosclerosis research is so adherent to an obviously
contradictory model of disease pathogenesis. I believe that
recounting how atherosclerosis research has arrived at this con-
clusion could help us to resolve this puzzle. Even taking into
account early work Rudolph Virchow and Carl von Rokitansky,
the credit for this scientific concept should be given to a series of
seminal experiments by Anitschkow and Chalatow [104] and
further elaborations by Anitschkow [22,105,106]. In his most
famous English publication, Anitschkow stated: ‘‘Lipids enter
the arterial wall as compounds with protein fractions of blood
plasma directly from arterial lumen’’ [107]. Already, at that time,
the extrapolations from the rabbit model (no natural cholesterol
consumption, no coronary DIT) to human coronary atherosclero-
sis (cholesterol consumption, coronary artery with significant DIT)
was criticized by experts [108,109]. Remarkably, observations of
early stages of human coronary atherosclerosis from the same
group had already shown initial lipid deposition not in the proxi-
mal but in the distal layers of DIT [79], thereby bearing some
contradictions to the hypothesis advanced by the authors. In
addition, the significance of proliferative morphogenesis in the
coronary tunica intima forming a diffuse intimal thickening, which
Anitschkow had hailed as crucial knowledge for atherosclerosis
research [22], was denounced in a later report from this group [110]
(the nature of the reasons behind such reversal is beyond the scope
of this review).
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FIGURE 6
During early stages of coronary atherosclerosis, the initial lipid deposition occurs in deep layers of the tunica intima, which are separated from the subendothelial
region by numerous cell layers and matrix. At the same time, the subendothelial region and the part of the tunica intima proximal to the outer endothelium do not
show any lipid accumulation. The initial lipid deposition in deep layers of the tunica intima occurred immediately above the internal elastic lamina and is not
accompanied by macrophage infiltration. Even with further accumulation of lipids in the deep tunica intima, lipid deposits never coincide with macrophage
infiltration. I indicates the intima and M is the media. (b,e,h,k,n,q) Sudan IV stain. (c,f,i,l,o,r) Immunostaining with anti-CD68 antibody (macrophages).
Arrowheads indicate internal elastic lamina. Bars represent 100 mm. DIT indicates diffuse intimal thickening and PIT is pathologic intimal thickening. Reproduced,
with permission, from [77]. This high-resolution image is courtesy of Dr Nakashima.
www.drugdiscoverytoday.com 1585
R
ev
ie
w
s
 F
O
U
N
D
A
T
IO
N
R
E
V
IE
W
REVIEWS Drug Discovery Today  Volume 21, Number 10 October 2016
R
eview
s
F
O
U
N
D
A
T
IO
N
R
E
V
IE
WA validity of the consensus lipid hypothesis of pathogenesis of
coronary atherosclerosis has been explicitly challenged in recent
times, notably by Stehbens [111–126] and Ravnskov [127–141].
Objections highlighted incoherencies of the accepted view and
offered alternative detailed pathogenetic models: hemodynamic
stress and aging by Stehbens [142–147] and infection hypothesis
with lipoproteins binding with microbes forming aggregates
impairing arterial vasa vasorum by Ravnskov, this impairment
was thought to be aggravated by hyperhomocysteinemia [148],
see also [149,150].
The Ravnskov and McCully hypothesis [148] on development of
the vulnerable plaque is of special importance because it could also
explain puzzling observations of small necrotic damage of the
coronary intima, occurring before atherosclerotic alterations; with
frequency of such necroses increasing with aging [151]. These
findings were reported by Velican and Velican (renowned experts
in coronary pathology) [151], and later were attributed to vaso-
spasm of the coronary vasa vasorum [152]. Although potent vasa
vasorum contraction is possible (e.g., shown as concentration-
dependent to administration of endothelin-1 and other endoge-
nous stimuli) [153,154], the Ravnskov–McCully hypothesis [148]
gives a parsimonious explanation for these early intimal necrotic
alterations. However, these (and some others) well-thought alter-
native hypotheses have never been considered by the accepted
mainstream opinion as pathogenetic models of the disease, al-
though today’s achievements in coronary atherosclerosis thera-
peutic treatment still are, at best, very modest.
Recently, the accepted view on coronary atherosclerosis patho-
genesis has been challenged again by new interpretation (Seneff
and coauthors) of the disease as the cholesterol sulfate deficiency
syndrome, emphasizing increased blood viscosity [155], actually
bridging to Ravnskov and McCully hypothesis [148]. It remains to
be seen whether this novel hypothesis could alter traditional
approaches in selection of therapeutic targets for treatment of
coronary atherosclerosis. Nevertheless, the hypothesis regarding
lipid invasion from the arterial lumen into the coronary wall was
further advanced in a series of publications by Ross and coauthors
[156–179] and formulated as ‘the response-to-injury hypothesis’
[160]. This hypothesis was proposed after experiments with de-
endothelialization of the iliac artery of Macaca nemestrina. This
experimental injury resulted in smooth muscle cell (SMC) prolifer-
ation and intimal thickening; the authors also suggested that the
loss of endothelial integrity facilitated lipid invasion from the
lumen into the arterial wall and stimulated SMC migration and
proliferation [156]. Interestingly, the initial hypothesis by Ross and
coauthors emphasized the proliferation of arterial SMCs in the
tunica intima as the initiation of the pathology [156–158,180],
whereas later analyses put an emphasis on the inflammatory nature
of coronary atherosclerosis [174,175,178,179]. Again, although the
research mentioned in one publication that the amount of intimal
smooth muscle increases with age [159], the series of publications
has depicted a normal coronary artery design with the tunica intima
as a single-cell-layer compartment [159,160,180].
However, because the following studies have shown that endo-
thelial injury is neither necessary nor sufficient for human coro-
nary atherosclerosis initiation (e.g., [181]) and because the
subendothelial space is highly accessible to lipoproteins even with
intact endothelium [182], the response-to-injury hypothesis was1586 www.drugdiscoverytoday.commodified. Williams and Tabas proposed the response-to-retention
hypothesis to accommodate new observations [49,183]. This hy-
pothesis proposed the subendothelial retention of atherogenic
lipoproteins as the central pathogenic process in atherosclerosis
[49,183,184]. Although stress-induced changes in the arterial wall
were suggested as important preconditions, subendothelial lipo-
protein retention was proposed as an absolute requirement for
atherosclerosis initiation, which could take place even in the
absence of stress-induced changes in the arterial wall
[49,183,184]. The response-to-injury hypothesis continued to be
adherent to the view that the human coronary tunica intima is a
single-cell-layer compartment or is negligible in respect to the
number of cell layers compared to tunica media [184–186]. Assump-
tions from this group on the initiation of human coronary ath-
erosclerosis are based on the perception of the coronary tunica
intima as a single cell layer or as a tissue compartment of insignifi-
cant thickness compared to tunica media. Notably, this depiction
appeared even in the publication by Tabas et al., in which the
authors reprinted the microscopic images of coronary arteries from
the Nakashima et al. publication (Fig. 4) showing that the tunica
intima is thicker than the tunica media [187]. The response-to-
injury hypothesis [156–179] and the response-to-retention hy-
pothesis [184–186] assumed that SMCs migrate from media to
intima and proliferate, thereby they refute initial intimal cell
proliferation as the pathogenesis of the disease.
Another research development supporting lipid invasion from
the arterial lumen into the coronary wall was carried out by
Hansson and coauthors [188,189]. Although this research was
mostly dedicated to pathology related to later events (mature
plaque), it undoubtedly supports the pathway of lipoprotein in-
vasion from luminal blood into the coronary wall [58,61]. Again,
the perception of this research is that the human coronary tunica
intima artery is a single-cell-layer compartment [58,61,63,66,190].
Undisputed facts on human coronary morphology and available
information on the initial patterns of lipid deposition into the
coronary wall
All of the above hypotheses are commonly based on two major
notions: (i) the presentation of the coronary tunica intima as a thin,
single-cell-layer compartment or a compartment with scarce re-
sidual cellularity; and (ii) the conjecture of lipid invasion from the
luminal site into the coronary artery wall. As we can see, the first
notion of coronary atherosclerosis research (the human coronary
tunica intima is a thin single-cell-layer compartment or a compart-
ment with scarce residual cellularity) contradicts all known facts of
human coronary morphology and thereby is purely incorrect. The
second notion could appear rational under the once-suggested
assumption that the human coronary tunica intima is vascularized
from the coronary lumen. This hypothesis has proposed the
nutrition of the tunica intima from a vascular net originating from
the arterial lumen [191] (republished as [192]). However, later
investigations have attributed the finding of ‘luminal vasculature’
to an inappropriately high pressure of a dye solution injected (ten
times higher than normal arterial pressure), for details see [93].
Later investigations either do not confirm luminal vasculature
in the human coronary at all or, at best, give it a negligible
role in intimal nutrition in normal and pathologic conditions
[93,193–196].
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nary tunica intima is an avascular compartment [197]. All observa-
tions showed that the normal human coronary tunica intima,
evolving from a single-cell-layer after birth to DIT in adults, is
always an avascular compartment and remains avascular in nor-
mal hearts throughout life. Several studies have investigated this
topic thoroughly and concluded that the coronary tunica intima
receives oxygen and nutrients through diffusion from the arterial
lumen and the medial vasa vasorum [93,198–202]. The previous
suggestion that the luminal vasculature can contribute to coro-
nary tunica intima nourishment [191,192] was never confirmed.
Therefore, when DIT attains a thickness of several-to-ten cell layers
(in humans, at approximately five years) the inner and outer
compartments of the tunica intima are exposed to various concen-
trations of blood constituents because diffusion is inversely pro-
portional to the square of the distance (i.e., DIT thickness). When
this distance is increased, as happens in adult coronary DIT, it
must be assumed that contact of outer (deeper) intimal layers with
certain blood constituents would be significantly minimized, if
not completely diminished. Therefore, for adult and normal aged-
thickened coronary tunica intima [22,203,204], the pattern of
nutrition by diffusion to the outer (deeper) intimal layers should
be assumed similar to that of the arterial media in the Wolinsky
and Glagov model, known as the ‘critical depth’ of avascular media
or ‘rule 290 [205]. Therefore, the second notion (lipid invasion
from a luminal site into the coronary artery wall) is not coherent
either with facts of avascular design of the tunica intima or with the
patterns of initial lipid deposition at the initiation of human
coronary atherosclerosis [77,78,80,81].
Paradoxical patterns of initial lipid deposition in the human
coronary artery
The facts are: (i) the initial lipid depositions have begun to appear
in human coronary atherosclerosis in a region of the coronary
tunica intima that is distal to the coronary lumen; (ii) no deposi-
tions are observed in regions of the tunica intima proximal to the
lumen at the same time. Using common sense, such a counterin-
tuitive pattern of initial lipid depositions constitutes a paradox.
Observations that are paradoxical to a hypothesis probably
occur in all scientific studies because observations often arrive
ahead of knowledge. There are two main ways paradoxical obser-
vations can be handled. One way is to supplement the initial
hypothesis by conditions under which a paradox could be
explained as a logical event. An alternative solution is to offer a
new hypothesis in which a paradoxical observation initially
appears as a logical event. Both approaches are valid and are
commonly used in scientific practice. Both approaches have also
been used to explain the paradoxical pattern of initial lipid accu-
mulation in coronary atherosclerosis – complementing the initial
hypothesis with new conditions [77,78,101,102] and offering a
new hypothesis [206]. However, such logical approaches are ex-
tremely rare in analyses of coronary atherosclerosis.
Surprisingly, mainstream analyses of coronary atherosclerosis
have chosen to pursue a third approach: presenting the consensus
hypotheses grounded on lipid invasion from the arterial lumen
while depicting the human coronary tunica intima as a thin, single-
cell-layer compartment and not mentioning the counterintuitive
distal lipid depositions. In such pathogenic models of coronaryatherosclerosis, the paradoxical initial deep lipid depositions are
simply omitted. I believe that we should not shrug off paradoxical
observations of disease initiation just because they could not be
explained by the consensus hypothesis, especially considering our
limited achievement in the prevention and cure of coronary ath-
erosclerosis [207,208]. I strongly believe that analysis of paradoxical
patterns of the disease initiation could help us think out of the box
and reveal obscure mechanisms of disease pathogenesis [206].
Could there be an alternative route for initial lipid depositions
into a deep part of coronary tunica intima?
Everything eventually comes to a simple question: if at the initia-
tion of coronary atherosclerosis lipids do not invade the coronary
wall from a coronary lumen proper where do they come from? If
there is no valid model of lipid invasion from the coronary lumen,
is there an alternative route via which lipids can come? Yes, there
is. This alternative route of lipid deposition is the vascularization
of the coronary tunica intima from the adventitial or medial vasa
vasorum, which has been shown by many studies to contribute to
coronary plaque progression and instability (bear in mind that
coronary plaques are confined to the coronary tunica intima)
[200,209–214].
The above plaque vascularization route has been shown by
numerous studies and is assumed to be the route from which
additional lipoproteins and inflammatory cells invade coronary
plaques and surrounding intimal tissues, significantly aggravating
pathology (i.e., plaque enlargement, instability and rupture)
[209,214–222]. These newly formed vessels originated from the
adventitial/medial vasa vasorum [209,214,216–225]. However, the
above research stops short from suggesting the adventitial/medial
vasa vasorum route as the source of lipid depositions as initiation of
coronary atherosclerosis. Moreno et al. suggested the following
hypothesis: ‘‘Adventitial-derived vasa vasorum neovascularization
develops under the trigger of oxidized low-density lipoprotein
deposits in the intima, mediated by hypoxia and Toll-like recep-
tors’’ [200], obviously designating intimal neovascularization as
the event induced by pre-existed lipoprotein depositions.
Therefore, if the above route, which is the alternative route to
lipid cell invasion from the coronary lumen, is undoubtedly
confirmed to contribute to advanced atherosclerotic pathological
formations in the coronary tunica intima, the inevitable question
is: could the same vascular route cause not only progression but
also the initiation of the disease? This question receives a positive
answer: yes, this route is very credible for the initiation of lipid
depositions. There are numerous observations showing that neo-
vascularization of the coronary tunica intima from the adventitial
vasa vasorum occurs under a variety of conditions before the
occurrence of any pathologic features in the coronary artery
[93,94,196,197,199–201,226–230].
This neovasculature extends from the tunica media vasculature,
penetrates the internal elastic lamina and forms a capillary net in
the deep layers of the coronary tunica intima [227,231]. This intimal
neovascularization pattern of the tunica intima is common for all
arterial DITs that begin to evolve into diseased conditions [226,229].
Adding these facts to the paradoxical initial lipid deposition in deep
distal layers of the tunica intima (where there is no initial lipid
deposition in layers proximal to the coronary lumen) has turned the
paradoxical initial lipid distribution into a logical event.www.drugdiscoverytoday.com 1587
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But why does the coronary tunica intima become vascularized in the
absence of any visible histopathologic alteration? What events in
the coronary wall would promote this morphogenesis? It is well
known that coronary atherosclerosis is an aging-related disease
[232–234]. After the coronary tunica intima differentiates from a
single-cell-layer compartment (after birth design) to a multi-layered
adult tunica intima (adult design) this compartment remains avas-
cular, receiving sufficient oxygen and nutrients through diffusion
from the arterial lumen and the adventitial vasa vasorum, terminat-
ing in two-thirds of the tunica media [93,199–202].
However, the cells of the tunica intima remain the most repli-
cating cell population in the arterial conduit including in the
coronary wall [235]. It has been long known that excessive cell
proliferation in coronary tunica intima can be triggered by a variety
of diverse nonspecific signals. Friedman writes: ‘‘. . .an artery
responds to almost any sort of physical or chemical injury to
which it may have been exposed with a hyperplasia or replication
of its surviving or still-intact remnants. Thus, whether the injury is
induced by transplantation, by needle puncture, by freezing, by
heat, by exposure to electron radiation, by induced hypertension,
by cholesterol infiltration, or by pressor amines, the typical re-
sponse on the tunic affected is a hyperplastic one’’ [236].
It has been confirmed by many studies that the coronary tunica
intima (i.e., DIT) gets thicker with aging, along with the tunica
intima of other large elastic arteries [203,237,238] and can transi-
tion from DIT to pre-PIT. However, whereas DIT occurs mostly
evenly in the coronary circumference [21], pre-PIT lacks regularity
and in some areas the tunica intima becomes initially enlarged
more than in others [239,240].
What happens when the coronary tunica intima becomes larger
owing to cell proliferation? A straightforward answer was given by
Osborn: ‘‘When the intima of the coronary artery exceeds a certain
thickness parts must either die or develop secondary blood sup-
ply’’ [241]. Because tissue hypoxia is a known inducer of angio-
genesis and neovascularization [242–244], neovascularization of
the hypoxic deep compartment of the enlarged coronary DIT from
the adventitial/medial vasa vasorum must follow coronary DIT
expansion. Therefore, the only logical deduction from the above
facts is that intimal proliferation and/or thickening causing neo-
vascularization as a result of hypoxia of deep layers of the tunica
intima opens a door for a direct lipid extraction from the leaky
neovasculature [242,243,245–247] by components of deep layers
of the tunica intima (i.e., by biglycan).
Because the biglycan in the deep tunica intima of the normal
adult human coronary is always separated from blood flow by
many cell or matrix layers, it is never exposed to certain blood
constituencies, and it is likely that blood lipoproteins are never in
contact with the deep compartment. In this sense, matrix com-
ponents of the deep layers of the coronary tunica intima can acquire
some properties of privileged tissue (high affinity to LDL-C) by
differentiating in a special environment, similar to the immuno-
logic privileges defined by developmental anatomy [248,249]. As
soon as newly formed capillary nets penetrate into deep layers of
the coronary tunica intima, which never were in contact with free
blood-flow before, biglycan (and possibly other matrix compo-
nents that evolved in such an avascular environment) starts to
bind lipoproteins and extracts them from the blood.1588 www.drugdiscoverytoday.comNew pathogenetic model of the initiation of coronary
atherosclerosis
This pathogenetic model of the initiation of coronary atheroscle-
rosis, which incorporates all facts (real morphologic design of
human epicardial coronary arteries, paradoxical patterns of lipid
deposition caused by preceding neovascularization of deep layers
of coronary tunica intima), was detailed in an early publication
[206] and is depicted here in Fig. 7. The above hypothesis also
explains why there is always a fibrous cap on top of a plaque
[83,213,250–252] – because plaques are always initiated under
fibromuscular tunica intima.
Suggested mechanism of the initiation of lipid deposition is not
unique to coronary atherosclerosis
The suggested mechanism of the initiation of lipid deposition
pathology is not unique. An identical mechanism, involving neo-
vascularization of a normally avascular tissue compartment, fol-
lowed by lipoprotein deposition, is well known for corneal lipid
keratopathy. The central cornea is normally an avascular compart-
ment [253–255]. More than 50 years ago, Cogan and Kuwabara
described cornea lipid keratopathy, consisting of lipid deposition in
the corneal substantia propria followed by fatty plaque formation, as
occurring only in corneal areas that have been previously neovas-
cularized [256]. The authors also pointed to morphologic similari-
ties between cornea lipid plaques and those in atherosclerosis and
suggested common pathogenesis [256]. In the following years,
numerous reports reaffirmed a causal role for neovascularization
in corneal lipid deposition and, hence, the main treatment modal-
ity has become the inhibition of neovascularization [253,254,257–
269]. It was also noted that the contribution of inflammation to this
pathogenesis is limited to the induction of angiogenesis [264].
Lipoprotein levels of the aqueous humor are thought to be close
to those of blood [270–275]. It is important to note that, although
the corneal substantia propria is separated from the aqueous humor
only by a single-cell-layer of Descemet epithelium, lipid depositions
were never (or extremely rarely [276]) observed before corneal
neovascularization. Interestingly, another member of the proteo-
glycan family, a small, leucine-rich lumican, which has a vital role
in embryonic development and tissue repair, is also predominantly
expressed in the adult cornea and in cells of thickened coronary
intima [277]. Lumican has also been implicated in lipid retention in
atherosclerosis [278]. These facts strongly favor the model of direct
lipid extraction from the permeable neovasculature into the cornea
proper rather than a diffusion model. The fact that a similar
sequence of events underlies the pathogenesis of the completely
unrelated corneal disease, in terms of neovascularization and lipid
deposition, reinforces the suggested new hypothesis on the mech-
anisms of coronary atherosclerosis [206].
Logic of scientific hypotheses
Facts showed that lipoprotein accumulation in coronary tunica
intima is not the initiation of coronary atherosclerosis but is a
consequence of enlarged intimal thickness, cell hypoxia and inti-
mal neovascularization. I completely agree with Geiringer’s asser-
tion that ‘‘. . . intimal vascularization is a function of intimal
thickness and not of atherosclerosis’’ [93]. Furthermore, enlarged
intimal hyperplasia, or pre-PIT (i.e., cell proliferation in tunica
intima), is the cause of coronary atherosclerosis.
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FIGURE 7
Schematic representations of the mechanism of coronary atherosclerosis. (a) Normal coronary artery. The coronary tunica intima forms diffuse intimal thickening
(DIT) with biglycan accumulations in the outer DIT, which is most distant from the arterial lumen. (b) DIT enlarged by cell proliferation forming pre-pathologic
intimal thickening (pre-PIT). Cells in the outer pre-PIT underwent hypoxia caused by increased diffusion distance. (c) Neovascularization of the outer pre-PIT from
the adventitial vasa vasorum. Newly formed vessels are highly permeable. (d) Biglycan of the outer pre-PIT comes into direct contact with blood low-density
lipoprotein cholesterol (LDL-C), which facilitates binding, retention and deposition of LDL-C in the outer PIT, whereas the inner part of PIT is free from lipoproteins.
This schematic stage (d) corresponds to fatty streak Grade 1 and Grade 2 in the Nakashima et al. study [62].
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atherosclerosis (where high levels of LDL-C is the major culprit) is
almost unanimously accepted, with only rarely a new hypothesis
challenge [155]. The consensus hypothesis has completely super-
seded an earlier viewpoint that coronary atherosclerosis is initiated
by proliferative intimal morphogenesis [279–281]. However, given
tremendous effectiveness of current lipid-lowering therapies, how
can we explain their inability to eradicate even a majority of
cardiovascular events [207]? Coronary atherosclerosis is the major
cause of cardiovascular events. How can we explain coronary
atherosclerosis in subjects with normal cholesterol levels [282],
and even in vegetarians [283,284]? It appears that the scientific
and medical communities are focusing on and emphasizing bio-
markers that can predict risk, without proof that these biomarkers
cause the risk [63,285].
Mechanisms of diseases constitute a fast-developing, state-of-
the-art scientific field, which often stretches beyond the scope of
established medical concepts. Although well recognized in the
past, medical concepts are not always proved to be correct;
the author believes that a newer hypothesis should not contra-
dict established concepts that have been proven to be correct so
far without good reasoning. Although thoughts on a cause
responsible for a phenomenon date back to Aristotle’s time,
applicability of the thesis to diseases was formulated by the
founder of the experimental medicine Claude Bernard: ‘‘Indeed,
proof that a given condition always precedes or accompanies a
phenomenon does not warrant concluding with certainty that a
given condition is the immediate cause of that phenomenon. It
must still be established that when this condition is removed, the
phenomenon will no longer appear. . .’’ [286].
It is well known that multiple factors participate during disease
development, and can affect the progression and severity of dis-
ease. However, we have to choose one or just a few factors that are
probably causative and potentially can constitute the therapeutic
targets. Therefore, only through distinguishing the cause from all
contributing factors can an effective therapeutic target be identi-
fied and a cure, leading to disease eradication, be achieved.
In modern medicine this thesis was formulated by William
Stehbens: ‘‘. . .differentiating between cause and non-causative fac-
tors is essential. Elimination of the latter only ameliorates or
reduces the incidence whereas elimination of the former eradicates
the disease. Swamps are not a cause of malaria. Draining swamps
may reduce the incidence of malaria but it is eradication of the
malarial parasites that eliminates the disease. Reduction in inci-
dence rather than elimination of the disease precludes a causal
relationship’’ [287]. The notion on refutability of the consensus
hypothesis on pathogenesis of coronary atherosclerosis was directly
addressed by Uffe Ravnskov [134]. In this light, facts that coronary
atherosclerosis occurs in subjects with normal cholesterol levels
[282], even in vegetarians [283,284], and lowering LDL-C levels
does not prevent cardiac events in the majority of those at risk of a
cardiovascular event [207] contradicts the causative role of LDL-C.
Concluding remarks
Although this review suggested that the uncontrollable cell pro-
liferation in coronary tunica intima, followed by neovasculariza-
tion, is the initiation of coronary atherosclerosis and a potential
therapeutic target, the analysis intends only to outline practical1590 www.drugdiscoverytoday.comimplementation of this suggestion. Although growing evidence
suggests that targeting the hypoxia pathway and intimal neovas-
cularization has a great therapeutic potential [288–290], even
with this achievement the presence of an enlarged hypoxic inti-
mal compartment in the coronary artery would still persist,
inducing neovascularization. The latter brings us back to the
Osborn notion: ‘‘When the intima of the coronary artery exceeds
a certain thickness parts must either die or develop secondary
blood supply’’ [241]. In regard to inhibition of intimal neovascu-
larization, this review also perceives obvious concerns about
antiangiogenesis therapy in subjects with an already jeopardized
myocardial blood supply. However, even if very local antiangio-
genesis actions become available, another side of such actions
should be considered.
It was suggested a long time ago by Groszek and Grundy that
the intimal neovasculature could be the route by which lipopro-
tein depositions can be extracted from coronary tunica intima [94].
It is worth to recall again that ‘‘. . . intimal vascularization is a
function of intimal thickness and not of atherosclerosis’’ [93].
This review suggests that, if coronary pathologic intimal thicken-
ing and initial lipoprotein depositions are diagnosed at early
stages of coronary atherosclerosis (Grade 1–2 fatty streaks, Grade
3 PIT), the disease could be reversible. If further cell proliferation
and expansion of coronary tunica intima are prevented at a stage
when lipoprotein depositions still reside in viable coronary tis-
sues, before forming a solid lipid compartment, neovasculariza-
tion of coronary tunica intima is a potentially crucial route for
lipoprotein removal and disease reversal [94]. The implementa-
tion of the suggestions above is an extremely difficult task but,
unless we start to work toward this goal, our research and thera-
peutic efforts will probably be off-target.
Finally, this review rests with the conclusion that uncontrolled
cell proliferation in tunica intima of human coronary arteries is the
initiation of the coronary atherosclerosis. Obviously, until an
enlarged coronary DIT compartment (i.e., pre-PIT) persists, it
continues causing hypoxia-inducing angiogenesis and neovascu-
larization of deep layers of coronary tunica intima and lipid extrac-
tion or deposition. Logically, uncontrolled cell proliferation in
coronary tunica intima is a cause of coronary atherosclerosis and
constitutes a therapeutic target. But is a coronary atherosclerosis
the only coronary disease in which intimal cell proliferation could
be implicated as the initiation of pathology? Of course not – I have
already mentioned that my attention to coronary atherosclerosis
was determined by its status as the number one killer in the
Western world. Of course, there are other coronary artery pathol-
ogies in which cell proliferation in the tunica intima is unanimous-
ly recognized as the major morphogenetic event. In the future we
will analyze coronary pathologies that are completely unrelated to
coronary atherosclerosis yet bear the same initiation hallmark –
cell proliferation in the coronary tunica intima.
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